Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight candida species and the CLSI M27-A3 broth microdilution method

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 916-922

  Pfaller, M A ^a,b   Espinel Ingroff, A ^c   Bustamante, B ^d   Canton, E ^e   Diekema, D J ^b   Fothergill, A ^f   Fuller, J ^g   Gonzalez, G M ^h   Guarro, J ⁱ   Lass Florl C ^j   Lockhart, S R ^k   Martin Mazuelos, E ^l   Meis, J F ^m,n   Ostrosky Zeichner, L ^o   Pelaez, T ^p   St Germain, G ^q   Turnidge, J ^r  

^a JMI LABORATORIES   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^d INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

ⁱ INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^k CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^l HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^m CANISIUS WILHELMINA HOSPITAL   (Netherlands)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^o UNIVERSITY OF TEXAS   (United States)

^p HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^q INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^r UNIVERSITY OF ADELAIDE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; MICAFUNGIN;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANADA; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; EUROPE; FKS GENE; FUNGAL GENE; FUNGUS ISOLATION; GENE MUTATION; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERU; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; SPECIES DIFFERENCE; UNITED STATES; WILD TYPE;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; ECHINOCANDINS; EUROPE; FUNGAL PROTEINS; GENE EXPRESSION; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; NORTH AMERICA; SOUTH AMERICA;

EID: 84893467170     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02020-13     Document Type: Article

References (27)

1. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group. 2012. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin. Microbiol. Infect. 18:19-37. http://dx.doi.org/10.1111/1469- 0691.12039.
2. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Filler SG, Fischer JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535. http://dx.doi.org/10.1086/596757.
3. Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Donnelly JP, Garbino J, Groll AH, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Cuenca-Estrella M, ESCMID Fungal Infection Study Group. 2012. ESCMID guideline for the diagnosis and management of Candida diseases: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin. Microbiol. Infect. 18:53-67. http://dx.doi.org/10.1111/1469-0691.12041.
4. Clinical and Laboratory Standards Institute. 2008. M27-A3. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2012. M27-S4. Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS, CLSI Subcommittee for Antifungal Testing. 2011. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist. Updat. 14:164-176. http://dx.doi.org/10. 1016/j.drup.2011.01.004.
7. Pfaller MA, Diekema DJ. 2012. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J. Clin. Microbiol. 50:2846-2856. http://dx.doi.org/10.1128/JCM.00937-12.
8. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Jones RN, Turnidge J, Diekema DJ. 2010. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J. Clin. Microbiol. 48:52-56. http://dx.doi.org/10.1128/JCM.01590-09.
9. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Osterlund A, Rodloff A, Steinbakk M, Urbaskova P, Vatopoulos A. 2003. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother. 52:145-148. http://dx.doi.org/10.1093/jac/dkg312.
10. Pfaller MA, Diekema DJ, Castanheira M, Jones RN. 2011. Definitions and epidemiology of Candida species not susceptible to echinocandins. Curr. Fungal Infect. Rep. 5:120-127. http://dx.doi.org/10.1007/s12281-011-0053-y.
11. Simjee S, Silley P, Werling HO, Bywater R. 2008. Potential confusion regarding the term 'resistance' in epidemiological surveys. J. Antimicrob. Chemother. 61:228-229. http://dx.doi.org/10.1093/jac/dkm423.
12. Turnidge J, Paterson DL. 2007. Setting and revising antibacterial susceptibility breakpoints. Clin. Microbiol. Rev. 20:391-408. http://dx.doi.org/10.1128/CMR.00047-06.
13. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Jones RN. 2011. Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. J. Clin. Microbiol. 49:3800-3804. http://dx.doi.org/10.1128/JCM.05047-11.
14. Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SRG, St-Germain G, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SRBS, Szeszs MW, Turnidge J. 2013. Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob. Agents Chemother. 57:5836-5842. http://dx.doi.org/10. 1128/AAC.01519-13.
15. Clinical and Laboratory Standards Institute. 2013. Minutes and agenda: Annual Meeting of Subcommittee for Antifungal Susceptibility Testing, Tampa, FL, 22 January 2013. Clinical and Laboratory Standards Institute, Wayne, PA.
16. Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Lass-Flörl C, Martin-Mazuelos E, Meis J, Pelaez T, Pfaller MA, Turnidge J. 2013. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method. Antimicrob. Agents Chemother. 57:3823-3828. http://dx.doi.org/10.1128/AAC.00636-13.
17. Canton E, Pemán J, Hervás D, Iñiguez C, Navarro D, Echeverría J, Martínez-Alarcón J, Fontanals D, Gomila-Sard B, Buendía B, Torroba L, Ayats J, Bratos A, Sánchez-Reus F, Fernández-Natal I, FUNGEMYCA Study Group. 2012. Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method. J. Clin. Microbiol. 50:3921-3926. http://dx.doi.org/10.1128/JCM.01730- 12.
18. Turnidge J, Kahmeter G, Kronvall G. 2006. Statistical characterization of bacterial wild-type MIC value distributions and determination of epidemiological cutoff values. Clin. Microbiol. Infect. 12:418-425. http://dx.doi.org/10.1111/j.1469-0691.2006.01377.x.
19. Turnidge J, Bordash G. 2007. Statistical methods for establishing quality control limits in Clinical and Laboratory Standards Institute susceptibility testing. Antimicrob. Agents Chemother. 51:2483-2488. http://dx.doi.org/10.1128/ AAC.01457-06.
20. Espinel-Ingroff A. 2003. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of literature. Rev. Iberoam. Micol. 20:121-136.
21. Messer SA, Jones RN, Fritsche TR. 2006. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J. Clin. Microbiol. 44:1782-1787. http://dx.doi.org/10.1128/JCM.44.5.1782-1787.2006.
22. Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. 2013. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J. Clin. Microbiol. 51:2571-2581. http://dx.doi.org/10.1128/JCM.00308-13.
23. Canton E, Pemán J, Gobernado M, Alvarez E, Baquero F, Cisterna R, Gil J, Martín-Mazuelos E, Rubio C, Sánchez-Sousa A, Serrano C. 2005. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study. Antimicrob. Agents Chemother. 49:1604-1607. http://dx.doi.org/10.1128/AAC.49.4. 1604-1607.2005.
24. Pfaller MA, Chaturvedi V, Diekema DJ, Ghannoum MA, Holliday NM, Killian SB, Knapp CC, Messer SA, Miskov A, Ramani R. 2008. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. J. Clin. Microbiol. 46:2155-2159. http://dx.doi.org/10.1128/JCM.00493-08.
25. Arendrup MC, Garcia-Effron G, Lass-Flörl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS. 2010. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and Iso-Sensitest media. Antimicrob. Agents Chemother. 54:426-439. http://dx.doi.org/10.1128/AAC.01256-09.
26. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN. 2010. Comparison of EUCAST and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J. Clin. Microbiol. 48:1592-1599. http://dx.doi.org/10.1128/JCM.02445-09.
27. Zimbeck AJ, Iqbal N, Ahlquist AM, Farley MM, Harrison LH, Chiller T, Lockhart SR. 2010. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from US population-based surveillance. Antimicrob. Agents Chemother. 54:5042-5047. http://dx.doi.org/10.1128/AAC.00836-10.